Q/C Technologies, Inc. Proceeds from (Repurchase of) Redeemable Preferred Stock
Q/C Technologies, Inc. (QCLS) reported Proceeds from (Repurchase of) Redeemable Preferred Stock of -$73.47 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock · last filed 2025-11-19
- Q/C Technologies, Inc. proceeds from (repurchase of) redeemable preferred stock for the quarter ending 2024-09-30 was $0.00.
- Q/C Technologies, Inc. proceeds from (repurchase of) redeemable preferred stock for the quarter ending 2024-06-30 was $0.00.
- Q/C Technologies, Inc. proceeds from (repurchase of) redeemable preferred stock for the quarter ending 2024-03-31 was -$73.47K.
- Q/C Technologies, Inc. proceeds from (repurchase of) redeemable preferred stock for fiscal 2023 was -$89.64K.
| Period end | Proceeds from (Repurchase of) Redeemable Preferred Stock 3 month | Proceeds from (Repurchase of) Redeemable Preferred Stock 6 month | Proceeds from (Repurchase of) Redeemable Preferred Stock 9 month | Proceeds from (Repurchase of) Redeemable Preferred Stock 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $0.00 derived: sum of 2 quarters · filed 2025-11-19 | -$73.47K 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$73.47K 10-Q · filed 2025-08-19 | ||
| 2024-03-31 | -$73.47K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$89.64K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |